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Many small lymphocytes in  mouse bone marrow display surface IgM molecules 
and receptors for Fc and complement (1-3). Cytocentrifuge rosetting studies demon- 
strate well-defined Fc and complement receptors on certain marrow small lympho- 
cytes, but the incidence of these cells relative to IgM-bearing lymphocytes is lower 
than in the peripheral lymphoid tissues (1, 2). These findings suggest that the Fc and 
complement receptor-bearing cells may form part of the population of young, B small 
lymphocytes  1 produced continuously in the marrow (4). If so, the timing and sequence 
of receptor development on small marrow lymphocytes would define stages in  the 
maturation of primary B lymphocytes, allowing a  correlation to be made with the 
onset  of  functional  responsiveness.  In  addition,  in  the  light  of  the  kinetic  and 
functional heterogeneity of marrow  lymphocytes (4,  5),  some Fc and complement 
receptor-bearing cells may represent  lymphocyte subtypes other than immature B 
lymphocytes. 
A majority of marrow small lymphocytes are newly formed cells, renewed rapidly 
by local cell production (4-7). After a postmitotic delay, many of these cells develop 
readily detectable surface IgM molecules increasing in apparent  density with time 
(8). Other young, marrow small lymphocytes, so-called null cells, lack both surface 
IgM and Thy.-1 antigen (2-5, 8). It remains to be verified whether all or only some 
of the null marrow lymphocytes actually belong to the B lineage, destined to develop 
surface IgM and other B-lymphocyte receptors as they mature. Newly formed marrow 
small lymphocytes in general migrate rapidly to the spleen and lymph nodes (9,  10) 
where their maturation may be completed (4,  11), In contrast, a  minority of small 
lymphocytes in the marrow are long-lived slowly renewed cells, mainly recirculating 
immigrants, which increase in numbers throughout postnatal life (4-6). Their receptor 
subtypes  are  unknown.  Numerically,  many of the  observed  Fc  and  complement 
receptor-bearing  lymphocytes in  the  marrow  could  be  long-lived  recirculating  B 
lymphocytes, rather than newly formed indigenous cells. 
Double-laheling experiments have now been performed to relate the surface receptor 
status of individual marrow lymphocytes to cell age and renewal, combining surface 
rosetting, and radioautographic DNA-labeling techniques. The aims of the studies 
were,  (a)  to compare the development of Fc and complement  receptors  on  newly 
formed marrow  small  lymphocytes with  that  of surface  IgM  and  to  examine the 
receptor  status  of proliferating  large  lymphoid  cells,  as  shown  by  the  rosetting 
*Supported by the Medical Research Council of Canada. 
1 Abbreviations used in this paper: B lymphocyte, lymphocyte bearing readily detectable surface  immuno- 
globulin, potential antibody-forming cell precursor;  CR, complement receptors;  FcR, Fc receptors;  FCS, 
fetal calf serum; MEM, minimum essential  medium; SRBC, sheep erythrocytes. 
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properties of cells labeled during a  continuous infusion of [3H]thymidine in vivo, (b) 
to characterize the surface receptors on long-lived marrow lymphocytes prelabeled by 
[3H]thymidine in vivo 3-5 wk previously, (c) to measure the degree to which marrow 
small lymphocytes may simultaneously express Fc or complement receptors as well as 
surface IgM,  using double-surface labeling by rosetting and  radioautographic anti- 
globulin-binding, respectively, (d) to determine whether young [3H]thymidine-labeled 
marrow  lymphocytes  can  continue  to  develop  surface  IgM,  Fc,  and  complement 
receptors after homing into the spleen of syngeneic recipients. The results contribute 
to a  model of primary B  lymphocyte maturation,  define some surface properties of 
presumptive  marrow  lymphocyte  progenitors  and  recirculating  cells,  and  provide 
evidence for the production in mouse bone marrow of some null lymphocytes which 
may not be destined to become B cells. 
Materials  and  Methods 
Animals.  Male, C3H/HeJ  mice (The Jackson Laboratory, Bar Harbor, Maine) were used 
when 9-10-wk old. 
[3H]Thymidine Labeling In Vivo.  To label newly formed cells, groups of four to five mice were 
injected intraperitoneally with 25 pCi [3H]thymidine (sp act 6.7 Ci/mM; New England Nuclear 
Corp., Boston, Mass.) followed immediately by a  subcutaneous infusion of [3H]thymidine (2 
#Ci  in 0.04  ml sterile water/g body wt)  as described (6).  Mice were killed at eight intervals 
from 1 h to 4 days. To label a fraction of long-lived cells, groups of five mice were given a daily 
intraperitoneal injection of 25 #Ci [3H]thymidine for  14 days and killed after a  further lag of 
3 wk to allow the disappearance of labeled rapidly renewed cells. 
Cells.  Bone marrow cells from groups of mice were flushed from the femoral diaphysis with 
cold Hepes-buffered Eagle's minimal essential medium (MEM) and 10% fetal calf serum (FCS), 
pooled, and washed, as described (1). 
Rosetting and Cytocentrifugation.  Fc and complement receptors and surface IgM were detected 
on marrow  lymphocytes by rosetting techniques, detailed elsewhere (1).  Briefly, marrow cell 
suspensions were mixed (1:30)  either with washed sheep erythrocytes (SRBC) coated with one 
of the  following:  (a)  mouse  anti-SRBC  antibody  (for  Fc  receptors),  (b)  rabbit  anti-SRBC 
stroma  antibody  (Cordis  Laboratories  Inc.,  Miami,  Fla.)  plus  normal  mouse  serum  (for 
complement receptors), (3) goat anti-mouse IgM antibody (Meloy Laboratories Inc., Spring- 
field, Va.)  (for  surface  IgM),  or  with  uncoated  SRBC  (controls).  The  cell  mixtures  were 
incubated in centrifuged pellets for 30 rain at either 37°C  (Fc and complement receptors), or 
0°C  (IgM),  resuspended,  and  cytocentrifuged.  Erythrocytes  attached  to  individual  small 
lymphocytes were counted, four or more erythroeytes being scored as rosettes. The incidence of 
any rosettes in control preparations (usually four to five erythrocytes) was subtracted from the 
values  for  rosettes of similar size in  experimental  preparations, to  give  the  specific rosette 
incidence and size distribution. 
Radioautographic Analysis.  Cytocentrifuged rosette preparations were methanol-fixed, coated 
with NTB2 emulsion (Eastman Kodak Co., Rochester, N.Y.), exposed at 4°C for 28 days and 
stained through the fixed emulsion with MacNeal's tetrachrome. After [3H]thymidine infusion, 
marrow small lymphocytes, identified as described elsewhere (I-8), were examined to record 
radioautographic  grains  over  the  nucleus  and  the  number  of surface-bound  erythrocytes. 
Positive [3H]thymidine labeling was set at four or more grains per cell, background counts over 
erythrocytes being negligible. Most labeled small lymphocytes had grain counts considerably 
higher than the threshold value. After control rosette correction, the  [3H]thymidine labeling 
index could thus be derived separately for the total marrow small lymphocyte population, and 
for the receptor-bearing (rosetting) and  receptor-negative (nonrosetting)  small lymphocytes, 
respectively. At each [3H]thymidine infusion interval, 1,700-4,200  (mean 2,300)  marrow small 
lymphocytes were examined for the total labeling index, the labeling indices of receptor-bearing 
cells being based on counts of-800 (650-1,000) small lymphocytes and 250  (150-500) rosettes. 
In  the  long-lived small  lymphocyte  experiments,  sets  of cytocentrifuge  preparations  were 
scanned  completely for  labeled small  lymphocytes and  their specific rosette incidence and 
rosette size distribution determined. W. C.  YANG, S.  C.  MILLER,  AND  D.  G.  OSMOND  1253 
Fi6.  1.  Small  lymphocytes  from bone marrow (a) and spleen (b) of mice infused  with aH-thymidine 
showing SH-thymidine labeling of the  nucleus and rosettes of adherent  erythrocytes indicating 
surface Fc receptors. (×  1,280). 
Double-Surface Labeling.  Pooled femoral marrow cells from groups of 5 mice were mixed in 
aliquots of 2  X  106 nucleated cells in 0.1  ml MEM-10% FCS for 30 min at 0°C with equal 
volumes of goat anti-mouse IgM serum (Meloy Laboratories Inc.), previously labeled with125I, 
as described (2). After washing through two discontinuous FCS gradients, the cells were mixed 
with coated SRBC for Fc and complement receptor rosettes, as described above, cytocentrifuged, 
and examined in radioautographs. Small lymphocytes were examined for surface IgM  (~.10 
grains) and either Fc or complement receptors (~4 SRBC). The proportion of small lymphocytes 
expressing one, both or neither surface marker was calculated. 
Homing of Newly Formed Marrow Small Lymphocytes to the Spleen.  Groups of five donor mice 
were infused subcutaneously with [3H]thymidine for 24 h, as described above. Doses of 20  × 
106 nucleated donor marrow cells, suspended in 0.5  ml  Hanks balanced salt solution, were 
injected into the tail veins of groups of 5 recipient mice, killed at  1, 2, and 3 days thereafter. 
Recipient spleen cells were suspended in MEM-10% FCS, rosetted for surface IgM, Fc, and 
complement receptors and examined radioautographically, as above. 
In each donor marrow,  1,000-2,000  labeled small lymphocytes were examined. Sets of 10 
cytocentrifuge preparations of each  recipient spleen  (m2,000  nucleated cells)  were  scanned 
completely for labeled small lymphocytes. 
Segments of the  spleen from  1 day  marrow  recipients were  also  fixed  in  Bouin's fluid, 
embedded in Epon (Shell Chemical Co.,  Division of Shell Oil Co., N.Y.),  serially sectioned (1 
ktm), stained with toluidine blue, prepared for radioautography, and exposed for 2 mo. Cells 
with five or more overlying grains were scored  as labeled, background grains being negligible. 
Results 
Development of Fc and Complement Receptors and Surface IgM on Newly  formed Marrow Small 
Lymphocytes.  Young small lymphocytes produced over a 4-day period were identified 
by radioautographic DNA-labeling during an infusion of [aH]thymidine, while their 
surface receptor status was simultaneously revealed by SRBC rosettes, as illustrated 
in Fig.  1. The contrasting cell markers were readily distinguished from one another, 
and the morphology of the rosette-forming cells was well preserved. 1254  MATURATION  OF  BONE  MARROW  LYMPHOCYTES 
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Fro.  2.  Percentage  of labeled  small lymphocytes in  the  bone  marrow  during continuous [aH]- 
thymidine infusion in vivo. 
Throughout  the  infusion period,  the  percentage  of marrow  small  lymphocytes 
forming rosettes for surface IgM (39.2  +  2.0%), Fc (25.2:1:  2.2%), and complement 
receptors (20.2  +  1.5%) remained unchanged and closely comparable with values in 
a previous nonradioautographic study (1). 
Fig. 2 shows the [3H]thymidine labeling of the total small lymphocyte population, 
resembling  previous  findings in  conventional smears  of mouse  marrow  (6-8)  and 
demonstrating  a  rapid  replacement  of nondividing small  lymphocytes by  newly 
formed cells derived from proliferating progenitors (4, 5). 
Fig.  3 shows the [aH]thymidine labeling index determined separately for surface 
IgM-rosetting and IgM-negative marrow small lymphocytes, respectively. The IgM- 
negative cells were the first to show labeling, which increased rapidly to 89-95% after 
2.5 days. IgM-bearing small lymphocytes showed an initial lag before undergoing a 
similarly rapid increase in labeling to 74% at 3 days. These cells showed a sequential 
increase in rosette size with age  (Fig.  4).  The youngest small lymphocytes formed 
rosettes of near-threshold size  (4-5  SRBC)  with only a  minimal initial lag in their 
appearance.  The  capacity to  form  larger  rosettes  developed  at  progressively later 
times, a  lag of more than a  day preceding the detection of any IgM-rosettes >  10 
SRBC per small lymphocyte. 
The [3H]thymidine labeling of Fc and complement receptor-bearing small lympho- 
cytes resembled that of IgM-bearing cells (Figs.  5, 6). After a short initial delay, the 
labeling increased rapidly to 80-83% at 3 days. In each case, receptor-negative small 
lymphocytes were the first to become labeled  (Figs.  5,  6).  However, no correlation 
between cell age and rosette size could be demonstrated. Fig. 7 shows the rosette size 
distribution of labeled small lymphocytes during [3H]thymidine infusion. In contrast W.  C.  YANG,  S.  C.  MILLER,  AND  D.  G.  OSMOND 
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FIG.  3.  [3H]Thymidine  labeling of surface IgM-negative and IgM-bearing small lymphocytes in 
the bone marrow during continuous [3H]thymidine  infusion in vivo. 
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Flo.  4.  [aH]Thymidine labeling of bone marrow small lym~hocytes forming surface IgM rosettes 
of various sizes (SRBC per lymphocyte) during continuous [ H]thymidine infusion in vivo. 1256  MATURATION  OF  BONE  MARROW  I,YMPHOCYTES 
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FIG.  5,  [~H]Thymidine  labeling of bone marrow small  lymphocytes defined by the  presence or 
absence of surface Fc receptors during continuous [3H]thymidine infusion in vivo. 
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FIc.  6.  [~H]Thymidine labeling of bone marrow small lympbocytes defined by  the presence or 
3  absence of surface complement receptors during continuous  H-thymidine infusion in vivo. W.  C. YANG, S.  C.  MILLER, AND D. G. OSMOND  1257 
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FIo.  7.  Size  distribution of rosettes for surface lgM (Ig), CR and FcR on [~H]thymidine-labeled 
small lymphocytes  in the bone marrow during [aH]thymidine  infusion in vivo. 
with  the IgM-bearing cells,  the  labeled  Fc and  complement receptor-bearing small 
lymphocytes showed no progressive increase in rosette size distribution with increasing 
labeling duration. 
In Fig. 8 the [aH]thymidine labeling data are expressed semilogarithmically as the 
disappearance  of unlabeled  cells  from  the  marrow.  The  labeling  indices  for  each 
receptor-bearing  and  receptor-negative  subset  of marrow  small  lymphocytes  con- 
formed to exponential  curves during  the  first  3  days of [3H]-thymidine infusion,  as 
demonstrated  previously for total and  Ig-bearing marrow small  lymphocytes (6-8). 
The one-half-renewal times for the total small lymphocytes and IgM-negative small 
lymphocytes were 23 and 17 h, respectively. The IgM-, Fc-, and complement receptor- 
bearing  small  lymphocytes  lagged  in  their  initial  appearance  behind  that  of the 
respective receptor-negative cells by 7,  7, and 9 h;  their one-half-renewal times were 
32, 24,  and 27 h, respectively. 
Fc  and  Complement  Receptors  and  Surface  IgM  on  Long-Lived  Marrow  Small 
Lymphocytes.  Table I  presents the incidence  and size distribution  of rosettes formed 
by a  fraction of the long-lived small lymphocytes in the bone marrow, prelabeled by 
[3H]thymidine in  vivo 3-5 wk previously. Counts  performed by Dr.  F.  P.  H. Chan 
(McGill University, Montreal, Canada)  revealed that many labeled cells had surface 
IgM, Fc, and complement receptors. In each case, the proportion of rosette-forming 
cells  was  actually  higher  among  the  long-lived  small  lymphocytes  than  the  total 
marrow  small  lymphocytes, especially  in  the  case of complement-receptor bearing 1258  MATURATION  OF  BONE  MARROW  LYMPHOCYTES 
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FIG.  8.  Disappearance of cells unlabeled by [3H]thymidine from the bone marrow populations of 
all small lymphocytes and of small lymphocytes defined by the presence or absence of surface FcR, 
and CR during continuous [3H]thymidine infusion in vivo. The regression lines were calculated by 
the method of least squares. 
TABLE  I 
Long-Lived Small Lymphocytes* in Bone Marrow." Incidence and Rosette Stze Distribution of Cells Forming 
Rosettes for Surface IgM, Fc, and Complement Receptors 
Surface marker 
Incidence of rosettes (%):~ formed 
by: 
Size distribution of rosettes (%)§ formed by long- 
lived small lymphocytes 
Long-lived  Total small 
small lympho-  lymphocytes  4-6 SRBC  7-9 SRBC  >10 SRBC 
cytes* 
IgM  42.8  36.7  35.2  24.2  40.6 
FoR  37.0  30.2  57.9  18.1  24.0 
CR  37.6  17.1  53.6  26.2  20.2 
* Small lymphocytes prelabeled with [SH]thymidine 3-5 wk previously. 
:~ For each surface marker,  1,500-4,000  total marrow small lymphocytes, including 115  240 labeled long- 
lived marrow small lymphocytes, were examined in cytocentrifuge rosette preparations using both coated 
and uncoated (control) SRBC. 
§ Adjusted with reference to a standard rosette size distribution profile of total marrow small lymphocytes 
common to this and the foregoing [SH]thymidine infusion study: the values may be compared with those 
of newly formed marrow small lymphocytes in Fig. 7. W. (3.  YANG, S. C.  MILLER, AND D. G. OSMOND  1259 
Fie. 9.  Small  lymphocytes  from bone marrow (a, h) and spleen (c) showing  surface IgM (radioau- 
tographic grains),  plus receptors for Fc (a, c) and complement (h) (SRBC rosettes) after sequential 
exposure to l~I-anti-IgM  antiserum  and cytocentrifuge  rosetting  procedures. (×  1,600). 
cells  (Table  I).  Long-lived small  lymphocytes bearing  receptors  for  either  Fc  or 
complement were almost as numerous as those having surface IgM, unlike the total 
marrow small lymphocyte population  in which complement receptor-bearing cells 
were less than one-half as numerous as IgM-bearing cells (Table I) (1). The size of the 
rosettes  formed  by  the  long-lived  small  lymphocytes  (Table  I)  was  consistently 
somewhat greater than those formed by either the total marrow small lymphocytes in 
the same experiment or the labeled newly formed marrow small lymphocytes during 
[3H]thymidine infusion (Fig. 7). 
Double-Surface Labeling of Bone Marrow Small Lymphocytes.  Some IgM-bearing marrow 
small lymphocytes  concomitantly showed Fc or complement receptors when examined 
by combined 12~I-antiglobulin  binding and surface rosetting. Examples are illustrated 
in Fig. 9. However, a55 and 20% of the Fc and complement receptor-bearing small 
lymphocytes, respectively, did not show surface IgM, whereas "60-70% of the IgM- 
bearing small lymphocytes had no receptors for Fc or complement (Fig.  10). 
Rosette Formation by Large Lymphoid Cells in Bone Marrow.  Measurements of marrow 
lymphocytes of all sizes in cytocentrifuge rosetting preparations showed that approx- 
imately one-quarter (24-27%) of all the rosettes for surface IgM, Fc, and complement 
receptors were formed by large lymphoid cells (> 10 #m nuclear diameter)  (1), which 
include the progenitors of small lymphocytes (4,  5).  As presented  in Table II, the 
various rosettes were formed by substantial proportions (31-62%)  of large lymphoid 
cells,  including cells in DNA synthesis and lymphoid cells in the largest subgroups 
(>13  #m  nuclear  diameter).  Although some  rosettes  were  of borderline  size  (4-5 
SRBC), many were larger (~6 SRBC)  (Table II). 
Development of Surface Markers  on Marrow Lymphocytes after Homing into the Spleen.  In 
donor marrow, one-third of the young labeled lymphocytes (0-24-h-old) showed some 
surface IgM by rosetting, whereas only 10% formed Fc receptor rosettes, and comple- 
ment receptor rosettes were almost absent (Fig. 11). When recovered from the spleens 
of normal syngeneic recipients, the proportion of labeled small lymphocytes bearing 1260  MATURATION OF BONE  MARROW  LYMPHOCYTES 
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small lymphocyte populations showing the incidence of surface IgM and of receptors for either Fc 
or complement. 
TABLE II 
Large Lymphoid Cells in Bone Marrow Forming Rosettes  for Surface IgM, Fc, and 
Complement Receptors 
Large lymphoid cells* 
Rosette size 
threshold 
(SRBC/ 
lymphoid  Surface 
cell)  lgM 
Proportion of large lymphoid cells form- 
ing rosettes for: 
FcR  CR 
% 
Total  >4  62  ',31  54 
>6  54  22  43 
DNA-synthesizing cells:~  >4  56  21  46 
>6  42  16  34 
Nuclear diameter: 
10-13 #m  >4  53  35  59 
>13 #m  >4  79  23  32 
* Lymphoid cells > 10 #m nuclear diameter in cytocentrifuge preparations. 
:[:Cells labeled in  radioautographs  1 h after [3HIthymidine injection  in  vivo: samples of 
150-260 total marrow lymphoeytes, including 39-50 labeled cells, were measured individ- 
ually in radioautographie cytocentrifuge preparations, to correlate surface rosette incidence 
with the size and DNA synthetic phase of marrow large lymphoid cells. 
each  surface  marker  increased  progressively with  time  (Fig.  11),  IgM-bearing cells 
increasing most rapidly, followed by Fc receptor-bearing cells. By 2 days, surface IgM 
and  Fc receptors were  demonstrable on  72  and  63%  of labeled small  lymphocytes, 
respectively, whereas  each  of the  small  number  of labeled cells detected  at  3  days 
showed surface IgM and Fc receptors. The incidence of complement receptor-bearing 
cells plateaued at 47-53% at 2-3 days. 
The  size of the  rosettes  formed  by  labeled marrow  small  lymphocytes  increased 
progressively  with  time  (Fig.  12).  Initially,  most  IgM  rosettes  were  small  (4-5 
erythrocytes) but, subsequently,  the proportion of medium  size rosettes  (6-10 eryth- 
rocytes)  increased,  whereas  large  rosettes  (>10  erythrocytes)  appeared  for  the  first 
time at 2 days. Similarly, Fc and complement receptor-bearing cells showed increasing 
proportions of medium size rosettes and a  delayed appearance of large rosettes after 
1-2 days (Fig.  12). 
In control preparations of donor marrow  cells mixed with  uncoated  erythrocytes, 
the labeled small lymphocytes showed  a  customarily low incidence of small rosettes W.  C.  YANG, S.  C.  MILLER, AND  D.  G.  OSMOND  1261 
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1 and  2  days after injecting the labeled bone marrow suspensions into normal syngeneic mice. 
(mean,  2.5%).  After  recovery from recipient  spleens,  the control rosettes  on labeled 
small  lymphocytes  were  increased  in  incidence  (mean,  17.1%),  though  not  in  size 
(mainly 4-5 erythrocytes). 
The  fraction of injected  labeled  lymphocytes  recovered  from the spleen  declined 
progressively with time (Table III). However, the absolute number of rosette-forming 
labeled cells recovered at  1-2 days actually exceeded  the number of comparable cells 
in  the  initial  marrow  inoculum  (Table  III).  In  the  case  of IgM-bearing  cells,  the 1262  MATURATION OF BONE  MARROW  LYMPHOCYTES 
TABLE III 
Number of Labeled Small Lymphocytes Forming Rosettes  for Surface IgM Molecules, 
Fc, and Complement Receptors in Donor Marrow and Recipient Spleen 
Labeled small lym- 
phocytes 
Number of [aH]thymidine-labeled  small lymphocytes  (X 
10  4  ) in: 
Bone marrow 
inoculum 
Recipient spleen after bone marrow injec- 
tion: 
1 day  2 days  3 days 
Total  120*  91 $  505  105 
Rosette-forming: 
Surface Ig  40  54  36  10 
FcR  12  28  32  10 
CR  0.7  16  22  5 
* Calculated from  the  total  number of nucleated marrow  cells  in  the  inoculum, 
together with the incidence and 24 h [aH]thymidine labeling index of marrow small 
lymphocytcs. 
$ Calculated from the percentage  of labeled small lymphocytes  in each preparation 
and the total number of small lymphocytes per spleen (101.2 o,.  1.3 ×  106). 
Fxc.  13.  [ZH]Thymidine labeled small lymphocyte (arrow) in splenic red pulp 1 day after trans- 
fusion of labeled bone marrow cells. (X  1,280). 
absolute  increase  at  1-2  days  was  particularly  marked  for  medium  size  rosettes, 
originally few in number. The appearance in the spleen of labeled small lymphocytes 
forming large IgM rosettes,  medium and large size Fc receptor rosettes,  and comple- 
ment receptor  rosettes  of all sizes was entirely an absolute phenomenon  because the 
total numbers of such cells were all negligible in the donor marrow. 
The  initial homing of labeled marrow-derived  small lymphocytes  into the  spleen 
occurred almost exclusively into the red pulp, as seen in radioautographic sections at 
1 day after marrow transfusion (55/57 cells observed)  (Fig.  13). I00 
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FIG.  14.  Two hypothetical maturation models of newly formed small lymphocytes in mouse bone 
marrow:  (A) a single developmental pathway with sequential appearance of surface Ig, FcR, and 
CR (left) or (B) a parallel maturation of multiple subtypes. The diagrams depiet the exponential 
renewal of small lymphocytes and the expression of surface receptors with time after the production 
of these cells from proliferating progenitors in the marrow. See text for further details. 
Discussion 
Production of Small Lymphocytes bearing Fc and Complement Receptors and Surface IgM in 
Mouse Bone Marrow.  The present kinetic study demonstrates that bone marrow small 
lymphocytes bearing  receptors  for  Fc  and  complement  form  part  of the  major 
population of indigenous rapidly-renewed marrow cells, and are not solely long-lived 
immigrants from the recirculating lymphocyte pool. At least 75-85% of the marrow 
small lymphocytes showing surface IgM,  Fc, and complement receptors  are  newly 
formed cells which display one or more of these surface components within 3 days of 
their production. In mice (7), as in other species (4, 5,  12), the newly formed marrow 
small lymphocytes are continuously generated from locally situated progenitors in the 
marrow. 
The findings confirm the large-scale production of IgM-bearing small lymphocytes 
in the marrow, previously demonstrated by radioautographic double-labeling tech- 
niques  (8). IgM-bearing small lymphocytes in  the  marrow  generally tend to  have 
lower  densities of surface  IgM  than  those  in  the  spleen,  as  shown  by binding of 
radiolabeled (2) and fluoreseeinated (13) anti-IgM antisera. A progressive increase in 
the effective density of surface IgM during cell maturation in the marrow is suggested 
in the present work by the progressive increase in the number of anti-IgM coated 
SRBC bound by marrow small lymphocytes with increasing cell age, paralleling a 
similar increase in their capacity to bind anti-IgM antiserum. 
The  production  in  the  marrow  of small  lymphocytes with  Fc and  complement 
receptors  raises the question of their interrelationships with IgM-bearing cells.  The 
simplest  interpretation  would  be  that  all  the  small  lymphocytes produced  in  the 
marrow represent only one cell lineage, developing into IgM-bearing B lymphocytes. 
A model of such a single population is depicted in Fig. 14 (A), based on the observed 1264  MATURATION OF BONE MARROW LYMPHOCYTES 
exponential renewal kinetics of the small lymphocyte population and the incidences 
of small lymphocytes bearing surface IgM, Fc, and complement receptors, respectively. 
Each small lymphocyte would be apparently receptorless when first produced and 
would express surface IgM, Fc, and complement receptors sequentially as it matured. 
The exponential renewal implies that cells  may leave the marrow at  random with 
respect to age, frequently before the surface receptors could be fully expressed (4, 8). 
For IgM-bearing cells alone, this model fits all previous data (4). However, for Fc and 
complement receptor-bearing small lymphocytes two predictions which would follow 
from the model could not be substantiated in the present work. (a) The lag before Fc 
and complement receptors  first appear should be appreciably longer than that  for 
surface IgM. In fact, although the data do not permit precise kinetic measurements, 
no difference in the mean lag times for the respective receptor-bearing populations 
could be demonstrated. (b) All cells having either Fc or complement receptors should 
simultaneously bear surface IgM.  However, whereas 30-40%  of IgM-bearing small 
lymphocytes do show concomitant  Fc or complement  receptors,  in  accord  with a 
progressive  maturation  of IgM-bearing  B  lymphocytes, many Fc  receptor-bearing 
small lymphocytes are IgM-negative and thus appear  to be a  separate population. 
These observations argue in  favor of more than one small lymphocyte maturation 
pathway in the marrow. 
Fig.  14  (B)  depicts  a  hypothetical  model  showing the  development  of various 
marrow small lymphocyte subtypes, incorporating the time lag and receptor overlap 
data, as well as the exponential renewal and incidences of the three types of receptor- 
bearing cells. In this model, the IgM-negative small lymphocytes fall into two main 
categoreis.  (a)  Some are  newly formed cells  which are  destined to develop surface 
IgM as well as Fc and complement receptors, representing the youngest, least mature 
small lymphocytes in the B lymphocyte lineage. This accords with evidence that some 
null small lymphocytes in the marrow (2, 8) and blood (14) rapidly develop surface 
IgM, in apparently increasing density (14),  when cultured in vitro.  (b)  Other IgM- 
negative small lymphocytes apparently do not develop surface IgM although they are 
in the marrow, though many of them do rapidly exhibit either Fc receptors or, in 
some cases,  complement receptors.  Fc and complement receptor-bearing cells have 
also been reported among the null small lymphocytes in human blood (15) and adult 
mouse spleen (16,  17). 
The  two  extreme  models  presented  in  Fig.  11  are  not  mutually exclusive  and 
current evidence indicates that the development of marrow small lymphocyte popu- 
lations includes features of both.  (a)  One lineage does develop Fc and complement 
receptors as well as surface IgM in a sequential fashion, representing the maturation 
of newly generated B lymphocytes. This concept is strongly supported by the present 
spleen homing study, discussed below.  (b)  Other newly formed marrow small lym- 
phocytes develop Fc receptors and, to a lesser extent, complement receptors, without 
concomitant surface IgM, at  short  intervals after their production and  apparently 
abruptly with respect to their rosette-forming capacities. The identity and potentials 
of this  apparently  large  and  rapidly  produced  population  of null  cells  are  being 
verified. 
Maturation  of Newly Formed, Marrow Derived Small Lymphocytes in  the Spleen.  Young 
marrow  small  lymphocytes, which  initially lack  surface  IgM  molecules,  Fc,  and 
complement receptors, sequentially express these surface components after migration 
into the spleen. Although all such cells appear to develop surface IgM molecules and W. C. YANG, S. C. MILLER, AND D. G. OSMOND  1265 
Fc receptors by 3 days, only approximately one-half develop complement receptors. 
This  receptor sequence  is  also shown by labeled newly formed small  iymphocytes 
normally appearing in the spleen of mice infused with [3H]thymidine in vivo (15). 
Parish  and  Hayward  (16) reported  in  rat  peripheral  lymphoid  tissues  that  some 
lymphocytes bearing both surface Ig and Fc receptors lacked complement receptors. 
The  present  studies  indicate  that  such  a  receptor  combination,  shown  by  some 
iymphocytes  in  the  marrow  (1),  blood  (17),  and  spleen  (16),  typifies  young  B 
lymphoeytes. 
A  similar receptor sequence is shown by developing B  lymphocytes as they first 
appear  in  ontogeny  (18-21)  during the  repopulation  of lymphoid tissues of adult 
irradiated  mice given syngeneic bone  marrow  (18) and  during lipopolysaccharide 
induction of B lymphocyte surface markers (22). In each case, complement receptors 
are  expressed  later  than  surface  IgM  and  Fc  receptors.  However,  the  ontogenic 
development of B lymphocytes and their continuing postnatal genesis in the marrow 
are not necessarily identical processes.  Apparent differences include the timing of the 
receptor sequence and the present observation in the marrow of two subpopulations 
of maturing IgM-bearing lymphocytes, distinguishable by their development or lack 
of complement receptors. 
The capacity of marrow-derived small lymphocytes in the spleen to form rosettes of 
increasing size for surface IgM, Fc, and complement receptors suggests that maturing 
B lymphocytes undergo a  progressive quantitative development of surface features, 
including receptor density or turnover. For surface IgM, these findings are consistent 
with those in  the marrow itself, as already noted.  Regarding Fc and complement 
receptors,  however,  newly formed small  lymphocytes within the  marrow  show no 
overall increase in rosette size with increasing cell age. Current studies aim to verify 
whether in  the marrow the development of small rosettes  for Fc and complement 
receptors on IgM-bearing lymphocytes may be overshadowed by an earlier appearance 
of large  rosettes  on  a  separate  lineage of IgM-negative lymphocytes. The  present 
findings suggest that most, if not all, of the labeled marrow null lymphocytes which 
home  into  the  spleen  are  committed  to  B-lymphocyte development.  Null  small 
lymphocytes normally present in the blood and spleen  (2,  14)  include immature B 
small lymphocytes (2, 3,  14), many of which would be newly formed cells migrating 
from marrow to spleen. However, apparently not all null small lymphocytes in the 
spleen are of this  type, because  some show a  low turnover rate  by [aH]thymidine 
labeling (23). 
Marrow  lymphocytes normally  migrate  preferentially  to  the  spleen.  The  high 
recovery of transfused young marrow small lymphocytes from the spleen in the present 
experiments  accords  with  their  homing  in  irradiated  guinea  pigs  (24) and  the 
migration of marrow lymphocytes under physiological conditions in vivo (9,  10). In 
vitro manipulation of transfused labeled cells may modify the cell surface, as suggested 
by a tendency to form small nonspecific rosettes with unsensitized SRBC, not shown 
by labeled young small lymphocytes in the spleens of mice receiving [3H]thymidine 
infusion  (15).  Nevertheless,  the  homing behavior of the cells and  the  use of non- 
irradiated  syngeneic  recipients,  suggests  that  the  present  experiments  mimic  the 
normal traffic of marrow lymphocytes. 
The extent to which the splenic environment is obligatory for the maturation of 
marrow-derived  small  lymphocytes  is  not  clear.  Although  the  maturation  of B 
lymphocytes from  transfused  progenitors  can  proceed  in  the  spleen  after marrow 1266  MATURATION OF BONE MARROW LYMPHOCYTES 
destruction by S9Sr (25, 26), splenectomy has little effect on the development of mouse 
B lymphocytes (27, 28),  and marrow lymphocytes show a  progressive maturation of 
surface IgM (3, 8) and functional responsiveness (29, 30) even when cultured in vitro. 
Newly formed marrow small  lymphocytes may be  precommitted  to  a  maturation 
sequence  which,  although  normally  proceeding  during  cell  migration  in  vivo,  is 
independent of the local environment. The converse possibility remains, viz. that cell 
migration depends upon cell surface development. The homing of marrow lympho- 
cytes into the splenic red  pulp  and the concomitant rapid development of surface 
receptors suggests that a surface maturation phase in the red pulp may be necessary 
before the cells can migrate into the white pulp (9, 24). 
The development of surface receptors  strongly suggests that the young, marrow- 
derived small lymphocytes which migrate into the spleen are virgin B lymphocytes. 
This view is supported by the similarity in the biological and kinetic properties of 
marrow lymphocytes and of virgin B lymphocytes, as defined by functional assays. 
Thus, many virgin B  lymphocytes in  the spleen are small cells  (11,  31,  32),  newly 
formed from proliferating precursors (11, 28) and having a short functional one half- 
life  (33).  The  marrow  itself contains  few cells  immediately responsive  to  primary 
antigens  (27,  29-31),  but  such  cells  rapidly  appear  when  marrow  cells  are  either 
cultured  (29,  30)  or  transferred  to  adoptive hosts  before antigenic challenge  (29). 
Similarly,  the  response  of marrow  cells  challenged  with  antigen  continuously in 
adoptive hosts  lags  behind  that  of spleen  cells by 22-4  days  (11,  34).  The  newly 
formed lymphocytes in the marrow apparently require another 1-4 days before they 
become immunologically responsive, corresponding with the period of receptor devel- 
opment in the present work and in vivo migration to peripheral lymphoid tissues. 
The brief persistence of labeled marrow lymphocytes in the spleen, as in previous 
intramyeloid labeling studies (9, 10), may reflect their short life span, dilution of label 
by cell activation and division, or cell efflux. Possibly, the cells may be activated for 
a limited period after maturing in the spleen, otherwise being lost by spontaneous cell 
death (4, 11, 28). Alternatively, the findings would not exclude a postulated two-stage 
development of virgin B lymphocytes (32),  an antigen-independent genesis of small 
iymphocytes being followed by nonspecific stimulation by environmental antigens 
into large proliferating cells (11, 28, 32). Some labeled large lymphoid cells appeared 
in the spleen in the present work, as in intramyeloid labeling and transfusion studies 
(9,  24).  The  extent  to  which  such  cells  may represent  either  the  proliferation  of 
transfused lymphocyte progenitors or the amplification of virgin small B lymphocytes 
by environmental antigens remains to be established. 
Long-Lived Small Lymphocytes bearing Surface IgM, Fc, and Complement Receptors in Mouse 
Bone Marrow.  The fact that  15-25%  of the various receptor-bearing marrow small 
lymphocytes remain unlabeled during [3H]thymidine infusion for 3-4 days suggests 
that  these  cells  belong to  the  population  of long-lived small  lymphocytes. This  is 
confirmed by the selective labeling of a  sample of long-lived cells in  the  marrow, 
nearly one-half of which show surface IgM, an appreciably greater proportion than 
that of newly formed (0-4-day-old) small lymphocytes (235% IgM + ve under iden- 
tical rosetting conditions). From the total incidence of long-lived small lymphocytes 
in the marrow of the mice used (~12%, (6)), and the total incidence of IgM-bearing 
small lymphocytes (39%) it may be calculated that at least  15% of the IgM-bearing 
small lymphocytes in the marrow belong to the long-lived population. Many of the 
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The incidence of both Fc and complement receptors on long-lived marrow small 
]ymphocytes resembles that of surface IgM, suggesting that all three surface markers 
are  present  simultaneously  on  these  cells.  This  contrasts  with  the  relatively  low 
incidence of complement receptors on newly formed small lymphocytes in the marrow 
or  spleen  (15),  suggesting  either  that  the  receptor  appears  subsequently,  or  that 
receptor-bearing cells are selected out during the development of the long-lived small 
lymphocyte pool  from  virgin  B  lymphocytes. The  resemblance  in  receptor status 
between long-lived small lymphocytes in  the marrow and  spleen  (15)  accords with 
evidence that  these cells form part of the same recirculating small lymphocyte pool 
(4, 5). 
In  peripheral  lymphoid  tissues  the  long-lived,  recirculating  small  lymphocytes 
include  memory  cells  mediating  secondary  immune  responses  (11).  The  present 
demonstration of both  IgM +ve and  IgM-ve  long-lived small  lymphocytes in  the 
marrow provides a  cellular basis  for the observations of Benner et al.  (35)  that  the 
development of numerous antibody-forming cells  in  the  marrow during secondary 
immune responses depends upon  immigrant  cells, including T  lymphocytes, which 
originate in the spleen after primary antigenic stimulation and circulate to the marrow 
(27, 35). 
Surface IgM, Fc, and Complement Receptors on Proliferating Lymphoid Cells in Mouse Bone 
Marrow.  Surface receptor rosettes are formed by some marrow lymphoid cells larger 
than  the  defined small  lymphocyte size  range.  Some of these  cells  may represent 
nondividing lymphocytes partially overlapping the large lymphoid cell population in 
size.  However, because rosettes are formed by cells in DNA synthesis and by some of 
the  largest  cells  in  the  whole  series,  this  must  also  be  a  property of some  of the 
proliferating large lymphoid cells, known to include the progenitors of small lympho- 
cytes (4, 5, 36). 
Previous  antiglobulin-binding  studies  in  mice  have  consistently  shown  marrow 
large lymphoid cells to be surface IgM-ve (2, 4, 8). On the other hand, Melchers et al. 
(37) described large cells located in the marrow but not in the spleen which synthesize 
7S IgM but release it rapidly, with little accumulation of IgM molecules in the cell 
membrane. Such cells may correspond with the marrow large lymphoid cells in the 
present  work.  If so,  the  current  rosetting  technique  affords  a  sensitive  means  of 
detecting transient surface IgM molecules, possibly because the multiplicity of  contacts 
between the SRBC and  the lymphocyte surface can  maintain  intercellular binding 
while IgM molecules are simultaneously shed and inserted in the cell membrane. The 
results raise the possibility that some marrow small lymphocyte progenitors already 
express B-lymphocyte surface markers at certain stages in their development. 
Summary 
Radioautographic DNA labeling and rosetting techniques were combined to study 
the development of surface IgM, Fc, and complement receptors (FcR, CR) on small 
lymphocyte populations  in  mouse bone marrow.  [3H]thymidine was  either infused 
continuously to label newly formed cells for periods up to 4 days, or injected daily, 
21-35 days before use, to label a  sample of long-lived cells.  Bone marrow cells were 
incubated with sensitized sheep erythrocytes to detect surface IgM,  FcR,  and  CR, 
respectively,  and  examined  radioautographically  after  cytocentrifugation.  During 
[3H]thymidine infusion, marrow small lymphocytes lacking surface markers were the 
first to show  [3H]thymidine labeling.  Most of these cells became labeled by 4  days 1268  MATURATION OF  BONE MARROW LYMPHOCYTES 
(IgM--ve, 89%;  FcR-ve, 92%;  Cr-ve, 88%).  Labeling of small lymphocytes bearing 
surface IgM, FcR, and Cr began after an initial lag and increased to high values by 
4  days  (IgM4-ve,  73%;  FcR+ve,  82%;  CR+ve,  83%).  Labeled  IgM+ve  small 
lymphocytes formed progressively larger rosettes as cell age increased. Some prolifer- 
ating large lymphoid cells formed rosettes for IgM, FcR, and CR. Labeled long-lived 
small  lymphocytes  expressed  surface  IgM,  FcR,  and  CR,  the  incidence  of each 
receptor being uniformly high  (38-43%)  and  the  rosettes tending to be larger than 
those formed by newly formed lymphocytes. In double-surface marker studies,  FcR 
and CR rosettes were formed by some IgM-ve small lymphocytes as well as IgM + ve 
cells in the marrow. After transfusion of marrow cells from donor mice infused with 
[3H]thymidine  for 24  h,  many labeled  newly  formed lymphocytes homed  into  the 
splenic red pulp of unlabeled syngeneic recipients.  Subsequently,  these cells showed 
a  rapid increase in the incidence of rosettes for surface IgM, FoR, and CR, together 
with a progressive enlargement of each type of rosette. Although all the labeled small 
lymphocytes recovered from the spleen  developed both surface IgM and  FcR  by 3 
days, only approximately one-half developed CR. The results demonstrate that most 
of the small lymphocytes bearing FcR, CR, and surface IgM in mouse bone marrow 
are  newly  formed  indigenous  cells.  Each  receptor  becomes detectable  by rosetting 
soon  after the  small  lymphocytes are  first  produced.  The  newly  formed,  marrow- 
derived  small  lymphocytes are able to continue  their development of surface IgM, 
FcR, and CR after migrating into the spleen, consistent with a maturation of primary 
B lymphocytes. In addition, the data indicate the genesis in mouse marrow of a non- 
B  lineage  of lymphocytes  (notably,  IgM-ve  FcR4- ve cells.).  A  minority  of small 
lymphocytes  bearing  IgM,  FcR,  and  CR  in  mouse  marrow  are  long-lived  cells, 
presumptive  recirculating  immigrants,  differing  in  receptor  status  from  the  newly 
formed cells.  The results  are discussed  with  regard  to the heterogeneity of marrow 
lymphocytes and  proposed  models of primary B  lymphocyte and  null  lymphocyte 
production. 
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